Table of Contents Global ADHD Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023 1 Market Overview 1.1 ADHD Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Stimulants (Amphetamines, Methylphenidate) 1.2.2 Non-Stimulants 1.2.3 Antidepressants 1.2.4 Blood Pressure Medicines 1.3 Market Analysis by Applications 1.3.1 Adults 1.3.2 Children 1.4 New Project SWOT Analysis of ADHD Drugs 1.5 Industry News Analysis of ADHD Drugs 2 Industrial Chain Analysis 2.1 Industry Chain Structure of ADHD Drugs 2.2 Raw Material Analysis of ADHD Drugs 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of ADHD Drugs 2.4 Other Costs Analysis of ADHD Drugs 2.5 Manufacturing Cost Structure Analysis of ADHD Drugs 2.6 Manufacturing Process Analysis of ADHD Drugs 2.7 Raw Materials Sources of ADHD Drugs Major Manufacturers in 2017 2.8 Downstream Buyers of ADHD Drugs 3 Global ADHD Drugs Players Profiles and Sales Data 3.1 Eli Lilly 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 ADHD Drugs Product Category, Application and Specification 3.1.2.1 Stimulants (Amphetamines, Methylphenidate) 3.1.2.2 Non-Stimulants 3.1.2.3 Antidepressants 3.1.3 Eli Lilly ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Eli Lilly Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Eli Lilly ADHD Drugs Volume in Different Applications and Its Application Share 3.2 Janssen Pharmaceuticals, Inc. 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 ADHD Drugs Product Category, Application and Specification 3.2.2.1 Stimulants (Amphetamines, Methylphenidate) 3.2.2.2 Non-Stimulants 3.2.2.3 Antidepressants 3.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Janssen Pharmaceuticals, Inc. Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Different Applications and Its Application Share 3.3 Shire 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 ADHD Drugs Product Category, Application and Specification 3.3.2.1 Stimulants (Amphetamines, Methylphenidate) 3.3.2.2 Non-Stimulants 3.3.2.3 Antidepressants 3.3.3 Shire ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Shire Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Shire ADHD Drugs Volume in Different Applications and Its Application Share 3.4 Perdue Pharma 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 ADHD Drugs Product Category, Application and Specification 3.4.2.1 Stimulants (Amphetamines, Methylphenidate) 3.4.2.2 Non-Stimulants 3.4.2.3 Antidepressants 3.4.3 Perdue Pharma ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Perdue Pharma Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Perdue Pharma ADHD Drugs Volume in Different Applications and Its Application Share 3.5 Glaxosmith Kline 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 ADHD Drugs Product Category, Application and Specification 3.5.2.1 Stimulants (Amphetamines, Methylphenidate) 3.5.2.2 Non-Stimulants 3.5.2.3 Antidepressants 3.5.3 Glaxosmith Kline ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Glaxosmith Kline Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Glaxosmith Kline ADHD Drugs Volume in Different Applications and Its Application Share 3.6 Novartis 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 ADHD Drugs Product Category, Application and Specification 3.6.2.1 Stimulants (Amphetamines, Methylphenidate) 3.6.2.2 Non-Stimulants 3.6.2.3 Antidepressants 3.6.3 Novartis ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Novartis Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Novartis ADHD Drugs Volume in Different Applications and Its Application Share 3.7 Celltech Group 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 ADHD Drugs Product Category, Application and Specification 3.7.2.1 Stimulants (Amphetamines, Methylphenidate) 3.7.2.2 Non-Stimulants 3.7.2.3 Antidepressants 3.7.3 Celltech Group ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Celltech Group Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Celltech Group ADHD Drugs Volume in Different Applications and Its Application Share 3.8 Johnson & Johnson 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 ADHD Drugs Product Category, Application and Specification 3.8.2.1 Stimulants (Amphetamines, Methylphenidate) 3.8.2.2 Non-Stimulants 3.8.2.3 Antidepressants 3.8.3 Johnson & Johnson ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Johnson & Johnson Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Johnson & Johnson ADHD Drugs Volume in Different Applications and Its Application Share 3.9.2.1 Stimulants (Amphetamines, Methylphenidate) 3.9.2.2 Non-Stimulants 3.9.2.3 Antidepressants 3.10.2.1 Stimulants (Amphetamines, Methylphenidate) 3.10.2.2 Non-Stimulants 3.10.2.3 Antidepressants 4 Global ADHD Drugs Market Competition by Manufacturers 4.1 Global ADHD Drugs Sales and Share by Manufacturers (2012-2017) 4.2 Global ADHD Drugs Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Market Concentration Rate 4.3.1 Top 3 ADHD Drugs Manufacturer Market Share 4.3.2 Top 6 ADHD Drugs Manufacturer Market Share 4.4 Market Competition Trend 5 Global ADHD Drugs Market Analysis by Regions 5.1 Global ADHD Drugs Sales, Revenue and Market Share by Regions 5.1.1 Global ADHD Drugs Sales by Regions (2012-2017) 5.1.2 Global ADHD Drugs Revenue by Regions (2012-2017) 5.2 North America ADHD Drugs Sales and Growth Rate (2012-2017) 5.3 Europe ADHD Drugs Sales and Growth Rate (2012-2017) 5.4 Asia-Pacific ADHD Drugs Sales and Growth Rate (2012-2017) 5.5 South America ADHD Drugs Sales and Growth Rate (2012-2017) 5.6 Middle East and Africa ADHD Drugs Sales and Growth Rate (2012-2017) 6 North America ADHD Drugs by Countries 6.1 North America ADHD Drugs Sales, Revenue and Market Share by Countries 6.1.1 North America ADHD Drugs Sales by Countries (2012-2017) 6.1.2 North America ADHD Drugs Revenue by Countries (2012-2017) 6.2 United States ADHD Drugs Sales and Growth Rate (2012-2017) 6.3 Canada ADHD Drugs Sales and Growth Rate (2012-2017) 6.4 Mexico ADHD Drugs Sales and Growth Rate (2012-2017) 7 Europe ADHD Drugs by Countries 7.1 North America ADHD Drugs Sales, Revenue and Market Share by Countries 7.1.1 Europe ADHD Drugs Sales by Countries (2012-2017) 7.1.2 Europe ADHD Drugs Sales by Countries (2012-2017) 7.2 Germany ADHD Drugs Sales and Growth Rate (2012-2017) 7.3 France ADHD Drugs Sales and Growth Rate (2012-2017) 7.4 UK ADHD Drugs Sales and Growth Rate (2012-2017) 7.5 Russia ADHD Drugs Sales and Growth Rate (2012-2017) 7.6 Italy ADHD Drugs Sales and Growth Rate (2012-2017) 8 Asia-Pacific ADHD Drugs by Countries 8.1 Asia-Pacific ADHD Drugs Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific ADHD Drugs Sales by Countries (2012-2017) 8.1.2 Asia-Pacific ADHD Drugs Sales by Countries (2012-2017) 8.2 China ADHD Drugs Sales and Growth Rate (2012-2017) 8.3 Japan ADHD Drugs Sales and Growth Rate (2012-2017) 8.4 Korea ADHD Drugs Sales and Growth Rate (2012-2017) 8.5 India ADHD Drugs Sales and Growth Rate (2012-2017) 8.6 ADHD Drugs Sales and Growth Rate (2012-2017) 9 South America ADHD Drugs by Countries 9.1 South America ADHD Drugs Sales, Revenue and Market Share by Countries 9.1.1 South America ADHD Drugs Sales by Countries (2012-2017) 9.1.2 South America ADHD Drugs Sales by Countries (2012-2017) 9.2 Brazil ADHD Drugs Sales and Growth Rate (2012-2017) 9.3 Argentina ADHD Drugs Sales and Growth Rate (2012-2017) 9.4 Columbia ADHD Drugs Sales and Growth Rate (2012-2017) 10 Middle East and Africa ADHD Drugs by Countries 10.1 Middle East and Africa ADHD Drugs Sales, Revenue and Market Share by Countries 10.1.1 Middle East and Africa ADHD Drugs Sales by Countries (2012-2017) 10.1.2 Middle East and Africa ADHD Drugs Sales by Countries (2012-2017) 10.2 ADHD Drugs Sales and Growth Rate (2012-2017) 10.3 UAE ADHD Drugs Sales and Growth Rate (2012-2017) 10.4 Egypt ADHD Drugs Sales and Growth Rate (2012-2017) 10.5 Nigeria ADHD Drugs Sales and Growth Rate (2012-2017) 10.6 South Africa ADHD Drugs Sales and Growth Rate (2012-2017) 11 Global ADHD Drugs Market Segment by Type 11.1 Global ADHD Drugs Sales, Revenue and Market Share by Type (2012-2017) 11.1.1 Global ADHD Drugs Sales and Market Share by Type (2012-2017) 11.1.2 Global ADHD Drugs Revenue and Market Share by Type (2012-2017) 11.2 Stimulants (Amphetamines, Methylphenidate) Sales Growth Rate and Price 11.2.1 Global Stimulants (Amphetamines, Methylphenidate) Sales Growth Rate (2012-2017) 11.2.2 Global Stimulants (Amphetamines, Methylphenidate) Price (2012-2017) 11.3 Non-Stimulants Sales Growth Rate and Price 11.3.1 Global Non-Stimulants Sales Growth Rate (2012-2017) 11.3.2 Global Non-Stimulants Price (2012-2017) 11.4 Antidepressants Sales Growth Rate and Price 11.4.1 Global Antidepressants Sales Growth Rate (2012-2017) 11.4.2 Global Antidepressants Price (2012-2017) 11.5 Blood Pressure Medicines Sales Growth Rate and Price 11.5.1 Global Blood Pressure Medicines Sales Growth Rate (2012-2017) 11.5.2 Global Blood Pressure Medicines Price (2012-2017) 11.6 Sales Growth Rate and Price 11.6.1 Global Sales Growth Rate (2012-2017) 11.6.2 Global Price (2012-2017) 12 Global ADHD Drugs by Application 12.1 Global ADHD Drugs Sales Market Share by Application (2012-2017) 12.2 Adults Sales Growth Rate (2012-2017) 12.3 Children Sales Growth Rate (2012-2017) 12.4 Sales Growth Rate (2012-2017) 12.5 Sales Growth Rate (2012-2017) 12.6 Sales Growth Rate (2012-2017) 13 Global ADHD Drugs Market Forecast (2018-2023) 13.1 Global ADHD Drugs Sales Volume, Revenue and Price Forecast (2018-2023) 13.1.1 Global ADHD Drugs Sales Volume and Growth Rate Forecast (2018-2023) 13.1.2 Global ADHD Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Global ADHD Drugs Price and Trend Forecast (2018-2023) 13.2 Global ADHD Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Global ADHD Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2023) 13.2.2 Global ADHD Drugs Revenue and Growth Rate Forecast by Regions (2018-2023) 13.2.3 Global ADHD Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including ADHD Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 North America (United States, Canada and Mexico) ADHD Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Europe (Germany, France, UK, Russia and Italy) ADHD Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) ADHD Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South America (Brazil, Argentina, Columbia) ADHD Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) ADHD Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.3 Global ADHD Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Global ADHD Drugs Sales Forecast by Type (2018-2023) 13.3.2 Global ADHD Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Global ADHD Drugs Price Forecast by Type (2018-2023) 13.4 Global ADHD Drugs Sales Volume Forecast by Application (2018-2023) 13.4.1 Global ADHD Drugs Sales Forecast by Application (2018-2023) 13.4.2 Global ADHD Drugs Market Share Forecast by Application (2018-2023) 14 Sales Channel, Distributors, Traders and Dealers 14.1 Sales Channel 14.1.1 Direct Marketing 14.1.2 Indirect Marketing 14.1.3 Marketing Channel Future Trend 14.2 Distributors, Traders and Dealers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology/Research Approach 16.2 Analyst Introduction 16.3 Data Source

List of Tables and Figures Figure ADHD Drugs Picture Table Product Specifications of ADHD Drugs Figure Global Sales Market Share of ADHD Drugs by Types in 2017 Table ADHD Drugs Types for Major Manufacturers Figure Stimulants (Amphetamines, Methylphenidate) Picture Figure Non-Stimulants Picture Figure Antidepressants Picture Figure Blood Pressure Medicines Picture Figure ADHD Drugs Sales Market Share by Applications in 2017 Figure Adults Picture Figure Children Picture Figure New Project SWOT Analysis of ADHD Drugs Table Industry News List of ADHD Drugs Figure Industry Chain Structure of ADHD Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of ADHD Drugs in 2017 Figure Manufacturing Process Analysis of ADHD Drugs Table Raw Materials Sources of ADHD Drugs Major Manufacturers in 2017 Table Major Buyers of ADHD Drugs Table Eli Lilly Basic Information List Table Eli Lilly ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly ADHD Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly ADHD Drugs Sales Global Market Share (%) (2012-2017) Figure Eli Lilly ADHD Drugs Revenue Global Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly ADHD Drugs Volume in Adults and Its Application Share Table Eli Lilly ADHD Drugs Volume in Children and Its Application Share Table Eli Lilly ADHD Drugs Volume in and Its Application Share Table Janssen Pharmaceuticals, Inc. Basic Information List Table Janssen Pharmaceuticals, Inc. ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Sales Growth Rate (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Sales Global Market Share (%) (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Revenue Global Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Adults and Its Application Share Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Children and Its Application Share Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in and Its Application Share Table Shire Basic Information List Table Shire ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Shire ADHD Drugs Sales Growth Rate (2012-2017) Figure Shire ADHD Drugs Sales Global Market Share (%) (2012-2017) Figure Shire ADHD Drugs Revenue Global Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Shire ADHD Drugs Volume in Adults and Its Application Share Table Shire ADHD Drugs Volume in Children and Its Application Share Table Shire ADHD Drugs Volume in and Its Application Share Table Perdue Pharma Basic Information List Table Perdue Pharma ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Perdue Pharma ADHD Drugs Sales Growth Rate (2012-2017) Figure Perdue Pharma ADHD Drugs Sales Global Market Share (%) (2012-2017) Figure Perdue Pharma ADHD Drugs Revenue Global Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Perdue Pharma ADHD Drugs Volume in Adults and Its Application Share Table Perdue Pharma ADHD Drugs Volume in Children and Its Application Share Table Perdue Pharma ADHD Drugs Volume in and Its Application Share Table Glaxosmith Kline Basic Information List Table Glaxosmith Kline ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Glaxosmith Kline ADHD Drugs Sales Growth Rate (2012-2017) Figure Glaxosmith Kline ADHD Drugs Sales Global Market Share (%) (2012-2017) Figure Glaxosmith Kline ADHD Drugs Revenue Global Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glaxosmith Kline ADHD Drugs Volume in Adults and Its Application Share Table Glaxosmith Kline ADHD Drugs Volume in Children and Its Application Share Table Glaxosmith Kline ADHD Drugs Volume in and Its Application Share Table Novartis Basic Information List Table Novartis ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis ADHD Drugs Sales Growth Rate (2012-2017) Figure Novartis ADHD Drugs Sales Global Market Share (%) (2012-2017) Figure Novartis ADHD Drugs Revenue Global Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis ADHD Drugs Volume in Adults and Its Application Share Table Novartis ADHD Drugs Volume in Children and Its Application Share Table Novartis ADHD Drugs Volume in and Its Application Share Table Celltech Group Basic Information List Table Celltech Group ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Celltech Group ADHD Drugs Sales Growth Rate (2012-2017) Figure Celltech Group ADHD Drugs Sales Global Market Share (%) (2012-2017) Figure Celltech Group ADHD Drugs Revenue Global Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Celltech Group ADHD Drugs Volume in Adults and Its Application Share Table Celltech Group ADHD Drugs Volume in Children and Its Application Share Table Celltech Group ADHD Drugs Volume in and Its Application Share Table Johnson & Johnson Basic Information List Table Johnson & Johnson ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson ADHD Drugs Sales Growth Rate (2012-2017) Figure Johnson & Johnson ADHD Drugs Sales Global Market Share (%) (2012-2017) Figure Johnson & Johnson ADHD Drugs Revenue Global Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson ADHD Drugs Volume in Adults and Its Application Share Table Johnson & Johnson ADHD Drugs Volume in Children and Its Application Share Table Johnson & Johnson ADHD Drugs Volume in and Its Application Share Table Basic Information List Table ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure ADHD Drugs Sales Growth Rate (2012-2017) Figure ADHD Drugs Sales Global Market Share (%) (2012-2017) Figure ADHD Drugs Revenue Global Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table ADHD Drugs Volume in Adults and Its Application Share Table ADHD Drugs Volume in Children and Its Application Share Table ADHD Drugs Volume in and Its Application Share Table Basic Information List Table ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure ADHD Drugs Sales Growth Rate (2012-2017) Figure ADHD Drugs Sales Global Market Share (%) (2012-2017) Figure ADHD Drugs Revenue Global Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table ADHD Drugs Volume in Adults and Its Application Share Table ADHD Drugs Volume in Children and Its Application Share Table ADHD Drugs Volume in and Its Application Share Table Global ADHD Drugs Sales by Manufacturer (2016-2017) Figure Global ADHD Drugs Sales Market Share by Manufacturer in 2016 Figure Global ADHD Drugs Sales Market Share by Manufacturer in 2017 Table Global ADHD Drugs Revenue by Manufacturer (2016-2017) Figure Global ADHD Drugs Revenue Market Share by Manufacturer in 2016 Figure Global ADHD Drugs Revenue Market Share by Manufacturer in 2017 Figure Top 3 ADHD Drugs Manufacturer (Revenue) Market Share in 2017 Figure Top 6 ADHD Drugs Manufacturer (Revenue) Market Share in 2017 Figure Global ADHD Drugs Sales and Growth Rate (2012-2017) Figure Global ADHD Drugs Revenue and Growth Rate (2012-2017) Table Global ADHD Drugs Sales by Regions (2012-2017) Table Global ADHD Drugs Sales Market Share by Regions (2012-2017) Table Global ADHD Drugs Revenue by Regions (2012-2017) Table Global ADHD Drugs Revenue Market Share by Regions in 2012 Table Global ADHD Drugs Revenue Market Share by Regions in 2017 Figure North America ADHD Drugs Sales and Growth Rate (2012-2017) Figure Europe ADHD Drugs Sales and Growth Rate (2012-2017) Figure Asia-Pacific ADHD Drugs Sales and Growth Rate (2012-2017) Figure South America ADHD Drugs Sales and Growth Rate (2012-2017) Figure Middle East and Africa ADHD Drugs Sales and Growth Rate (2012-2017) Figure North America ADHD Drugs Revenue and Growth Rate (2012-2017) Table North America ADHD Drugs Sales by Countries (2012-2017) Table North America ADHD Drugs Sales Market Share by Countries (2012-2017) Figure North America ADHD Drugs Sales Market Share by Countries in 2012 Figure North America ADHD Drugs Sales Market Share by Countries in 2017 Table North America ADHD Drugs Revenue by Countries (2012-2017) Table North America ADHD Drugs Revenue Market Share by Countries (2012-2017) Figure North America ADHD Drugs Revenue Market Share by Countries in 2012 Figure North America ADHD Drugs Revenue Market Share by Countries in 2017 Figure United States ADHD Drugs Sales and Growth Rate (2012-2017) Figure Canada ADHD Drugs Sales and Growth Rate (2012-2017) Figure Mexico ADHD Drugs Sales and Growth Rate (2012-2017) Figure Europe ADHD Drugs Revenue and Growth Rate (2012-2017) Table Europe ADHD Drugs Sales by Countries (2012-2017) Table Europe ADHD Drugs Sales Market Share by Countries (2012-2017) Table Europe ADHD Drugs Revenue by Countries (2012-2017) Table Europe ADHD Drugs Revenue Market Share by Countries in 2012 Table Europe ADHD Drugs Revenue Market Share by Countries in 2017 Figure Germany ADHD Drugs Sales and Growth Rate (2012-2017) Figure UK ADHD Drugs Sales and Growth Rate (2012-2017) Figure France ADHD Drugs Sales and Growth Rate (2012-2017) Figure Russia ADHD Drugs Sales and Growth Rate (2012-2017) Figure Italy ADHD Drugs Sales and Growth Rate (2012-2017) Figure Asia-Pacific ADHD Drugs Revenue and Growth Rate (2012-2017) Table Asia-Pacific ADHD Drugs Sales by Countries (2012-2017) Table Asia-Pacific ADHD Drugs Sales Market Share by Countries (2012-2017) Table Asia-Pacific ADHD Drugs Sales Market Share by Countries (2012-2017) Table Asia-Pacific ADHD Drugs Revenue by Countries (2012-2017) Table Asia-Pacific ADHD Drugs Revenue Market Share by Countries (2012-2017) Figure China ADHD Drugs Sales and Growth Rate (2012-2017) Figure Japan ADHD Drugs Sales and Growth Rate (2012-2017) Figure Korea ADHD Drugs Sales and Growth Rate (2012-2017) Figure India ADHD Drugs Sales and Growth Rate (2012-2017) Figure Southeast Asia ADHD Drugs Sales and Growth Rate (2012-2017) Figure South America ADHD Drugs Revenue and Growth Rate (2012-2017) Table South America ADHD Drugs Sales by Countries (2012-2017) Table South America ADHD Drugs Sales Market Share by Countries (2012-2017) Figure South America ADHD Drugs Sales Market Share by Countries in 2017 Table South America ADHD Drugs Revenue by Countries (2012-2017) Table South America ADHD Drugs Revenue Market Share by Countries (2012-2017) Figure South America ADHD Drugs Revenue Market Share by Countries in 2017 Figure Brazil ADHD Drugs Sales and Growth Rate (2012-2017) Figure Argentina ADHD Drugs Sales and Growth Rate (2012-2017) Figure Columbia ADHD Drugs Sales and Growth Rate (2012-2017) Figure Middle East and Africa ADHD Drugs Revenue and Growth Rate (2012-2017) Table Middle East and Africa ADHD Drugs Sales by Countries (2012-2017) Table Middle East and Africa ADHD Drugs Sales Market Share by Countries (2012-2017) Figure Middle East and Africa ADHD Drugs Sales Market Share by Countries in 2017 Table Middle East and Africa ADHD Drugs Revenue by Countries (2012-2017) Table Middle East and Africa ADHD Drugs Revenue Market Share by Countries (2012-2017) Figure Middle East and Africa ADHD Drugs Revenue Market Share by Countries in 2012 Figure Middle East and Africa ADHD Drugs Revenue Market Share by Countries in 2017 Figure Saudi Arabia ADHD Drugs Sales and Growth Rate (2012-2017) Figure UAE ADHD Drugs Sales and Growth Rate (2012-2017) Figure Egypt ADHD Drugs Sales and Growth Rate (2012-2017) Figure Nigeria ADHD Drugs Sales and Growth Rate (2012-2017) Figure South Africa ADHD Drugs Sales and Growth Rate (2012-2017) Table Global ADHD Drugs Sales by Type (2012-2017) Table Global ADHD Drugs Sales Share by Type (2012-2017) Table Global ADHD Drugs Revenue by Type (2012-2017) Table Global ADHD Drugs Revenue Share by Type (2012-2017) Figure Global Stimulants (Amphetamines, Methylphenidate) Sales Growth Rate (2012-2017) Figure Global Stimulants (Amphetamines, Methylphenidate) Sales Price (2012-2018) Figure Global Stimulants (Amphetamines, Methylphenidate) Sales Growth Rate (2012-2017) Figure Global Non-Stimulants Sales Price (2012-2018) Figure Global Antidepressants Sales Growth Rate (2012-2017) Figure Global Antidepressants Sales Price (2012-2018) Figure Global Blood Pressure Medicines Sales Growth Rate (2012-2017) Figure Global Blood Pressure Medicines Sales Growth Rate (2012-2018) Table Global ADHD Drugs Sales by Application (2012-2017) Table Global ADHD Drugs Sales Share by Application (2012-2017) Figure Global Adults Sales Growth Rate (2012-2017) Figure Global Children Sales Growth Rate (2012-2017) Figure Global ADHD Drugs Sales, Revenue and Growth Rate (2018-2023) Table Global ADHD Drugs Sales Forecast by Regions (2018-2023) Table Global ADHD Drugs Market Share Forecast by Regions (2018-2023) Figure North America Sales ADHD Drugs Market Forecast (2018-2023) Figure Europe Sales ADHD Drugs Market Forecast (2018-2023) Figure Asia-Pacific Sales ADHD Drugs Market Forecast (2018-2023) Figure South America Sales ADHD Drugs Market Forecast (2018-2023) Figure Middle East and Africa Sales ADHD Drugs Market Forecast (2018-2023) Table Global ADHD Drugs Sales Forecast by Type (2018-2023) Table Global ADHD Drugs Market Share Forecast by Type (2018-2023) Table Global ADHD Drugs Sales Forecast by Application (2018-2023) Table Global ADHD Drugs Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Eli Lilly Janssen Pharmaceuticals, Inc. Shire Perdue Pharma Glaxosmith Kline Novartis Celltech Group Johnson & Johnson